In vitro models to determine the pharmacokinetic parameters
Abstract
The pharmaceutical industry seeks to more efficient and precise determination of the main pharmacokinetic parameters of existing and new drugs, and therefor uses new in vitro models that show a high degree of correlation with in vivo response.
Determination of intestinal absorption, metabolic transformations and metabolic profile of drugs is carried out using the laboratory in vitro models, which represent innovative basis for determination of absorption, distribution, metabolism and elimination (ADME) of drugs .
The aim of this paper is to present three most important in vitro models, their properties and applications in the pharmaceutical industry when determining the pharmacokinetic parameters.
The rapid development of the pharmaceutical industry expressed the need for in vitro models for the determination of pharmacokinetic parameters in the laboratories that want to increase their operational efficiency and effectiveness.
Keywords: pharmacokinetics, drugs, parameters, in vitro models
Full Text:
PDFReferences
Hunter J, Jepson MA, Tsuruo T, Simmons NL, and Hirst
BH
Functional expression of P-glycoprotein in apical membranes
of human intestinal caco-2 cells. kinetics of vinblastine
secretion and interaction with modulators. J Biol Chem
: 199, 14991-14997.
Cummins CL, Mangravite LM, and Benet LZ, Characterizing
the expression of CYP3A4 and efflux transporters
(P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2
cells after induction with sodium butyrate and the phorbol
ester 12-O-tetradecanoylphorbol-13-acetate. Pharm
Res18:2001,1102-1109
Hidalgo IJ, Raub TJ, and Borchardt RT. Characterization
of the human colon carcinoma cell line (Caco-2) as a model
system for intestinal epithelial permeability. Gastroenterology
: 1989; 736-749.
Bermejo, M. et al. PAMPA – a drug absorption in vitro
model 7. Comparing rat in situ, Caco-2, and PAMPA permeability
of fluoroquinolones. Pharm. Sci., 21:2004; 429-
Avdeef, A. et al. Caco-2 permeability of weakly basic drugs
predicted with the Double-Sink PAMPA pKaflux method.
Pharm. Sci., 24:2005; 333-349
Shane C. Gad, Preclinical Development Handbook: ADME
and Biopharmaceutical properties, John Whiley and Sons
Inc, 2008.
Refbacks
- There are currently no refbacks.